Prevalence and control of dyslipidemia among persons with diabetes in the United States.

Abstract Objective : We assessed the prevalence, treatment, and control of dyslipidemia among United States (U.S.) adults with diabetes. Methods : Among 498 adults (projected to 13.4 million) aged ≥18 years with diabetes representative of the U.S. population and surveyed within the cross-sectional National Health and Nutrition Examination Survey 1999–2000, control of lipids was classified according to American Diabetes Association criteria. The extent of low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and triglyceride (TG) control was examined by gender and ethnicity, in comparison to those without diabetes, and according to lipid-lowering treatment. Analyses were weighted to the U.S. population. Results : Less than one-third of men and only one-fifth of women with diabetes are in control for LDL-C, defined as p Conclusion : Many persons with diabetes remain uncontrolled for dyslipidemia. Intensified efforts at screening and treatment according to current guidelines are warranted.